Online citations, reference lists, and bibliographies.
← Back to Search

Encapsulation Of Clozapine Into Polycaprolactone Nanoparticles As A Promising Strategy Of The Novel Nanoformulation Of The Active Compound

S. Łukasiewicz, A. Mikołajczyk, M. Szczęch, K. Szczepanowicz, P. Warszyński, M. Dziedzicka-Wasylewska
Published 2019 · Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
Clozapine (CLO), an atypical antipsychotic used in the clinic for treatment of schizophrenia, has a well-known efficacy, but its general use in clinical practice is limited because of the risk of serious side effects. Therefore, in the present work, we focused on the encapsulation of CLO into polymeric polycaprolactone nanoparticles (PCL NPs) and studies of interactions of this nanoformulation with model cells. Two types of clozapine PCL NPs (CLO-PCL NPs), pegylated and non-pegylated, were obtained by nanoemulsion templating method. The complex interactions of these NPs with three model cell lines (HEK 293, human embryonic kidney cell line; RAW 264.7, murine macrophage cell line; hCMEC/D3, model of blood-brain barrier, BBB) were studied. Cell viability, cellular uptake of NPs, NO release, expression of pro-inflammatory agents and transcytosis experiments were performed. Pegylated CLO-PCL NPs showed better results in the tests performed in the present study, in comparison to non-pegylated ones: they are not toxic to model cells; pegylated outer surface protected from their fast uptake by macrophages; they were not immunogenic; transcytosis experiments pointed to their ability to cross a model BBB. The results obtained in the present study indicate that pegylated CLO-PCL NPs are promising carrier for antipsychotic drugs directed to cross BBB. The experiments were conducted using only in vitro models but they provide valuable data in the field of nanotechnology which can be used in novel molecular pharmacology.
This paper references
10.1016/S0927-7765(02)00160-1
Interactions of phospholipid- and poly(ethylene glycol)-modified surfaces with biological systems: Relation to physico-chemical properties and mechanisms
P. Vermette (2003)
10.1007/s11011-014-9621-5
Clozapine linked to nanocapsules minimizes tissue and oxidative damage to biomolecules lipids, proteins and DNA in brain of rats Wistar
Angélica Aparecida Costa Güllich (2014)
10.1002/PAT.4375
Overview on natural hydrophilic polysaccharide polymers in drug delivery
F. Abedini (2018)
10.3390/nano8100860
Antibacterial and Bioactive Surface Modifications of Titanium Implants by PCL/TiO2 Nanocomposite Coatings
A. Kiran (2018)
10.1038/aps.2014.113
Oral delivery of capsaicin using MPEG-PCL nanoparticles
W. Peng (2015)
10.1080/14740338.2016.1191468
Clozapine’s critical role in treatment resistant schizophrenia: ensuring both safety and use
G. Remington (2016)
10.1211/jpp.58.4.0001
Can drug‐bearing liposomes penetrate intact skin?
Gamal M.M. El Maghraby (2006)
10.1186/s13036-018-0106-7
A facile in vitro platform to study cancer cell dormancy under hypoxic microenvironments using CoCl2
H. R. Lee (2018)
10.1016/j.jconrel.2016.01.033
Importance of dual delivery systems for bone tissue engineering.
M. Farokhi (2016)
10.1186/1471-244X-14-102
Clozapine: a review of clinical practice guidelines and prescribing trends
S. Warnez (2014)
10.1016/j.canlet.2015.08.022
Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.
Sang-soo Kim (2015)
10.2147/IJN.S190164
An efficient and long-acting local anesthetic: ropivacaine-loaded lipid-polymer hybrid nanoparticles for the control of pain
A. Li (2019)
10.1016/j.colsurfb.2017.01.006
Testing of bioactive-nanovesicles on hepatotoxicity of atypical antipsychotics via digital holography.
Fatma Ozturk Kirbay (2017)
10.1002/smll.200901158
Effect of surface properties on nanoparticle-cell interactions.
Ayush Verma (2010)
10.3109/08923973.2013.828744
Regulation of macrophage immune responses by antipsychotic drugs
M. Chen (2013)
Safety and efficacy of combined clozapineazathioprine treatment in a case of resistant schizophrenia associated with Behcet’s disease: a 2-year follow-up
D De Berardis (2013)
[On the clinical relevance of clozapine-triggered release of cytokines and soluble cytokine-receptors].
T. Pollmächer (2001)
10.1186/2045-8118-10-16
The hCMEC/D3 cell line as a model of the human blood brain barrier
B. Weksler (2012)
10.1002/1097-4636(20010905)56:3<406::AID-JBM1110>3.0.CO;2-R
Chain-length dependence of the protein and cell resistance of oligo(ethylene glycol)-terminated self-assembled monolayers on gold.
B. Zhu (2001)
10.1166/JBNS.2014.1201
Extracellular Biosynthesis, Characterization and Antibacterial Activity of Silver Nanoparticles Synthesized by Bacillus subtilis (NCIM—2266)
M. Saravanan (2014)
10.1016/j.actbio.2012.09.022
Polysaccharide gene transfection agents.
Wahid Khan (2012)
10.1097/YIC.0000000000000241
Proinflammatory and anti-inflammatory biomarkers in schizophrenia and influence of simvastatin on the interleukin-6
L. P. Francesconi (2019)
10.3109/10837450.2014.965324
Formulation and characterization of clozapine and risperidone co-entrapped spray-dried PLGA nanoparticles
Apoorva Panda (2016)
10.1021/nl0722929
Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers.
Pascale R. Leroueil (2008)
10.1016/j.euroneuro.2012.10.016
Nanopsychiatry—The potential role of nanotechnologies in the future of psychiatry: A systematic review
G. Fond (2013)
Toxic potential mater . Nanolevel
A Nel (2006)
10.1016/j.jconrel.2015.03.020
Silk fibroin nanoparticle as a novel drug delivery system.
F. Mottaghitalab (2015)
10.1055/S-2001-16533
Zur klinischen Relevanz der Wirkung von Clozapin auf die Freisetzung von Zytokinen und löslichen Zytokinrezeptoren
T. Pollmächer (2001)
10.1021/BC060077Y
Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability.
Seungpyo Hong (2006)
10.1016/0169-409X(95)00022-Y
Which polymers can make nanoparticulate drug carriers long-circulating?
V. Torchilin (1995)
10.1016/J.IJPHARM.2005.10.010
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.
Donald E. Owens (2006)
10.1002/jbm.a.36145
Transferrin-conjugated magnetic dextran-spermine nanoparticles for targeted drug transport across blood-brain barrier.
M. Ghadiri (2017)
10.1124/dmd.112.044925
Nano-Advantage in Enhanced Drug Delivery with Biodegradable Nanoparticles: Contribution of Reduced Clearance
R. Kadam (2012)
10.1016/j.schres.2017.01.016
Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications
F. T. Ali (2017)
10.1016/j.ijpharm.2016.01.040
Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
Mona Alibolandi (2016)
10.1177/2042098618756261
Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine
D. De Berardis (2018)
10.1016/j.jconrel.2008.03.007
Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26.
Zhiqing Pang (2008)
10.1186/2045-8118-10-33
Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood–brain barrier model for drug permeability studies
D. Eigenmann (2013)
10.1007/s11095-012-0958-3
Effects of Particle Size and Surface Modification on Cellular Uptake and Biodistribution of Polymeric Nanoparticles for Drug Delivery
S. Kulkarni (2012)
10.1016/S0079-6123(08)00909-6
In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
H. Meltzer (2008)
10.1088/0957-4484/25/33/335706
A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma.
M. Lupi (2014)
10.1080/21691401.2019.1596923
Comparative in vitro transportation of pentamidine across the blood-brain barrier using polycaprolactone nanoparticles and phosphatidylcholine liposomes
Geofrey Omarch (2019)
10.1021/la901565q
Aqueous-core lipid nanocapsules for encapsulating fragile hydrophilic and/or lipophilic molecules.
N. Anton (2009)
10.1016/j.biomaterials.2012.07.046
Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.
Hongliang Xin (2012)
10.1021/acs.langmuir.5b01226
Biocompatible Polymeric Nanoparticles as Promising Candidates for Drug Delivery.
S. Łukasiewicz (2015)
10.1021/mp800051m
Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
F. Alexis (2008)
10.1002/adhm.201600914
Cell Guidance on Nanostructured Metal Based Surfaces
Yulia Zhukova (2017)
10.1016/J.JCONREL.2005.06.006
Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.
K. Manjunath (2005)
10.1038/nrd1033
Effect of pegylation on pharmaceuticals
J. Harris (2003)
10.1016/J.COLSURFA.2017.07.009
Neuroprotective action of undecylenic acid (UDA) encapsulated into PCL nanocarriers
M. Szczęch (2017)
10.2174/1389450043345407
Drug delivery systems: past, present, and future.
R. Mainardes (2004)
10.1186/s13036-018-0108-5
Engineering and monitoring cellular barrier models
J. Yeste (2018)
10.1016/j.colsurfb.2016.05.065
A surface modification of clozapine-loaded nanocapsules improves their efficacy: A study of formulation development and biological assessment.
S. M. Vieira (2016)
10.1166/JNN.2016.11668
Clozapine-Loaded Polysorbate-Coated Polymeric Nanocapsules: Physico-Chemical Characterization and Toxicity Evaluation in Caenorhabditis elegans Model.
BarbraKatyúscya Sanches Moraes (2016)
10.1176/appi.ajp.2016.16050503
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.
O. Howes (2017)
10.1126/SCIENCE.1114397
Toxic Potential of Materials at the Nanolevel
A. Nel (2006)
10.1517/17425247.2015.974547
Production of nanoparticle drug delivery systems with microfluidics tools
I. Khan (2015)
10.1007/s10895-014-1437-5
Synthesis of AS1411-Aptamer-Conjugated CdTe Quantum Dots with High Fluorescence Strength for Probe Labeling Tumor Cells
Mona Alibolandi (2014)
10.1021/LA981356F
Polymer Brushes that Resist Adsorption of Model Proteins: Design Parameters
A. Halperin (1999)
10.3390/molecules23082087
Current Concepts and Treatments of Schizophrenia
P. Stępnicki (2018)
10.1192/BJP.BP.115.177261
Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis.
D. Siskind (2016)
10.1016/j.micpath.2018.01.038
Synthesis of silver nanoparticles from Bacillus brevis (NCIM 2533) and their antibacterial activity against pathogenic bacteria.
M. Saravanan (2018)
10.1002/14651858.CD000059.pub2
Clozapine versus typical neuroleptic medication for schizophrenia.
A. Essali (2009)
10.1016/j.genhosppsych.2012.06.007
Safety and efficacy of combined clozapine-azathioprine treatment in a case of resistant schizophrenia associated with Behçet's disease: a 2-year follow-up.
D. De Berardis (2013)
10.1021/acs.molpharmaceut.5b00828
Composite Nanoformulation Therapeutics for Long-Term Ocular Delivery of Macromolecules.
Vibhuti Agrahari (2016)
10.2147/IJN.S188169
Tailor-made PL-UC-C3 nanoparticles for fluorescence/computed tomography imaging-guided cascade amplified photothermal therapy
X. Xie (2018)
10.1016/j.colsurfb.2015.12.044
Encapsulation of clozapine in polymeric nanocapsules and its biological effects.
S. Łukasiewicz (2016)
10.1021/jp805026m
Lipid bilayer curvature and pore formation induced by charged linear polymers and dendrimers: the effect of molecular shape.
H. Lee (2008)
NANOPARTICLES AS DRUG DELIVERY SYSTEMS
V. Sivalalitha (2012)
10.1016/j.colsurfb.2017.07.053
The interaction of clozapine loaded nanocapsules with the hCMEC/D3 cells - In vitro model of blood brain barrier.
S. Łukasiewicz (2017)
10.1080/14740338.2016.1201475
An update of safety of clinically used atypical antipsychotics
L. Orsolini (2016)
10.1016/S0142-9612(01)00267-8
Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake.
Y. Zhang (2002)
10.1016/j.ijpharm.2014.02.037
Influence of particle geometry and PEGylation on phagocytosis of particulate carriers.
R. Mathaes (2014)
10.2174/157488612800492681
Update on the adverse effects of clozapine: focus on myocarditis.
D. De Berardis (2012)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar